Press Digest: New York Times business news - May 17

Horizon Therapeutics

17/05/2023 04:45

May 17 (Reuters) - The following are the top stories on
the New York Times business pages. Reuters has not verified
these stories and does not vouch for their accuracy.
    
    - The U.S. Federal Trade Commission on Tuesday sued to block
the drug maker Amgen's  AMGN.O  $27.8 billion acquisition of the
pharmaceutical company Horizon Therapeutics  HZNP.O , saying it
would thwart competition in the drug industry.
    
    - Elon Musk, the chief executive of Tesla  TSLA.O , warned
shareholders Tuesday to expect a difficult year because of an
unsteady global economy and high interest rates.
    
    - U.S. President Biden vetoed legislation on Tuesday that
would have reinstated tariffs on solar panels from Chinese
companies in Southeast Asia that had been found to be imported
into the United States in violation of trade rules.
    
    - Florida legislation that was designed to hamstring Disney
 DIS.N  could end up helping the company, at least in relation
to a lawsuit in state court over development at Walt Disney
World near Orlando.
    
    - Sam Altman, the chief executive of the San Francisco
start-up OpenAI, testified before members of a Senate
subcommittee and largely agreed with them on the need to
regulate the increasingly powerful A.I. technology being created
inside his company and others like Google  GOOGL.O  and
Microsoft  MSFT.O .

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))